- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
全球资产投资机会定位分化再现;欧洲央行及美联储会议前的交易及持仓状况
GOAL:
vs.
2016
2016 12
70
QE /
500
QE
/2015 50
ETF
vs. /
111 Europe vs. US equity performance 100
US$/EUR
109 80
US/ Bund 10-yr rate differential (RHS)
107 60
105 40
103 20
101 0
99 -20
97 -40
bps
95 -60
1 year before first Fed rate hike 1 year after
We revisit our GOAL asset allocation ahead of the ECB (December 3) and Fed (December
16), and in context of the key themes and forecasts from our economists outlooks (see
Global Economics Analyst: A Stealthy Path to Full Employment, November 18, 2015 and Global
Markets Analyst: Top 10 Market Themes for 2016, November 19, 2015). Our economists expect a
moderate pick-up in global growth driven by a stabilization of hard-hit EM economies and a small
acceleration in Europe and Japan. While the recovery has disappointed on GDP growth, G7
unemployment rates have declined at their fastest rate since 1970. Key risks are: Rate shock,
sharp oil price declines and China Yuan devaluation.
Over 12-months, a pick-up in growth coupled with smaller declines in commodity prices
supports a gradual move higher in inflation and our pro-risk asset allocation (Overweight
equities, Underweight bonds). We remain constructive on equities, mainly for Europe and
Japan. However, the return trajectory is flattening compared to the last 5 years. With the market
priced for a shallow rate hike cycle and bonds still underpricing inflation risk, in our view
您可能关注的文档
- 仿制药一致性深度分析报告仿制药一致性评价加速优质药企CRO辅料企业面临机遇.pdf
- 仿制药一致性评价专题报告我在春天等你.pdf
- 仿制药行业深度研究报告2015扬帆出海开辟新空间.pdf
- 仿制药一致性评价专题研究一致性评价开启仿制药强国之路.pdf
- 企业移动互联网势不可挡空间5000亿.pdf
- 企业内控系统内控10到内控20.pdf
- 企业软件的两极Palantir和Slack.pdf
- 伊利股份600887深度分析报告三力合一全球布局打造千亿食品航母.pdf
- 企业级服务SaaS系列报告之一美国SaaS行业十年发展之路回顾.pdf
- 企业级服务系列报告二国内发展路径探讨与SaaS公司盈利评估方法.pdf
文档评论(0)